Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Molecular Pharmaceutics|August 24, 2013
Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatmentVanna Sanna, Imtiaz Ahmad Siddiqui, Mario Sechi, et al.
Journal of Medicinal Chemistry|January 13, 2018
Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal AdenocarcinomaYuting Kuang, Mario Sechi, Salvatore Nurra, et al.
Molecules (Basel, Switzerland)|November 17, 2007
Hyperbranched molecular structures with potential antiviral activity: derivatives of 5,6-dihydroxyindole-2-carboxylic AcidMario Sechi, Fabio Casu, Ilaria Campesi, et al.
European Journal of Medicinal Chemistry|August 24, 2019
Discovery of novel functionalized 1,2,4-triazoles as PARP-1 inhibitors in breast cancer: Design, synthesis and antitumor activity evaluationAhmed T A Boraei, Pankaj K Singh, Mario Sechi, et al.
Annals of the New York Academy of Sciences|June 26, 2015
Resveratrol nanoformulation for cancer prevention and therapyImtiaz A Siddiqui, Vanna Sanna, Nihal Ahmad, et al.
Bioorganic & Medicinal Chemistry|May 3, 2005
Search for the pharmacophore in prazosin for Transport-PPatricia A Zunszain, Cesare Federico, Mario Sechi, et al.
International Journal of Nanomedicine|November 21, 2015
Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatmentVanna Sanna, Jean Christopher Chamcheu, Nicolino Pala, et al.
Journal of Agricultural and Food Chemistry|January 20, 2015
Polymeric nanoparticles encapsulating white tea extract for nutraceutical applicationVanna Sanna, Giuseppe Lubinu, Pierluigi Madau, et al.
Journal of Medicinal Chemistry|May 4, 2016
Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer CellsVanna Sanna, Salvatore Nurra, Nicolino Pala, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2012
Inhibition of α-class cytosolic human carbonic anhydrases I, II, IX and XII, and β-class fungal enzymes by carboxylic acids and their derivatives: new isoform-I selective nanomolar inhibitorsMario Sechi, Alessio Innocenti, Nicolino Pala, et al.
Pageof 8